UPMC Health System Cardiologists Study New Treatment For Atrial Fibrillation

October 20, 1997

PITTSBURGH, Oct. 17 -- Cardiologists at UPMC Health System are the first in the U.S. to study a new treatment for atrial fibrillation, a condition in which the heart beats irregularly and very rapidly.

Called radiofrequency catheter ablation, the procedure combines sophisticated imaging techniques with virtual reality, allowing doctors to create a map of the inside of the heart and short circuit abnormal electrical impulses which cause the irregular beats.

An estimated two million Americans have atrial fibrillation and about 15 percent of strokes are attributable to the disorder.

"Until now there has not been an effective non-drug treatment for atrial fibrillation," said David Schwartzman, M.D., assistant professor of medicine in the division of cardiology and director of the Atrial Fibrillation Consultation and Advanced Therapies Center at UPMC Health System. "The outcome of this approach has been, for the most part, dismal because of drug inefficacy and/or adverse side effects. With our aging population, the prevalence of this disease has increased steadily and will continue to do so."

Physicians insert a catheter into the upper chamber of the heart (atrium) and using intracardiac echocardiography and a new magnetic imaging technique called CARTOŠ, they can determine the exact location of the tip of the catheter at all times. They then use this information to map the inside of the heart and reconstruct a real-time three- dimensional view of the heart on a high-resolution computer monitor with no x-ray exposure.

Guided accurately to within .09 mm by the three-dimensional images, the physicians use radiofrequency energy to create a series of lesions in the atrium.

"There are a large number of circuits in the atria and these lesions create barriers to conduction between the different areas and stop irregular heart beats," Dr. Schwartzman said. "This procedure is minimally invasive."

The procedure usually takes 3 to 5 hours during which time patients are under light sedation. Patients are monitored overnight and discharged from the hospital the following day.

"The technique has been used in approximately 30 patients at three centers in Europe over the past six months," Dr. Schwartzman said. "Thus far atrial fibrillation suppression has been achieved in more than 75 percent of the patients."

Dr. Schwartzman is leading a multicenter, FDA-approved trial in the United States of the procedure. The study is funded by Biosense, Inc., manufacturer of the CARTOŠ system.

For additional information about UPMC Health System, please access http://www.upmc.edu.

University of Pittsburgh Medical Center

Related Atrial Fibrillation Articles from Brightsurf:

Atrial fibrillation less deadly than it used to be, but still cause for concern: BU study
A first-of-its-kind study by researchers from the Boston University School of Public Health (BUSPH) shows a decline in deaths related to atrial fibrillation (irregular heartbeat) over the last 45 years.

Postoperative atrial fibrillation does not impact on overall survival after esophagectomy
Volume 11, Issue 25 of Oncotarget reported that Administration of landiolol hydrochloride was found to be associated with reduced incidence of atrial fibrillation after esophagectomy for esophageal cancer in our previous randomized controlled trial.

People with atrial fibrillation live longer with exercise
More than 100,000 Norwegians have atrial fibrillation. They should be actively exercising for their health.

Atrial fibrillation among overweight people is not due to fat
In a recently published study, researchers from Aarhus University document that the risk of atrial fibrillation is not linked to the amount of body fat, but instead to large muscle mass, or more precisely, a high fat-free weight

Eating more protein could help ward off atrial fibrillation in women
Women who ate slightly more than the recommended daily amount of protein were significantly less likely to develop atrial fibrillation (AFib), a dangerous heart rhythm disorder that can lead to stroke and heart failure, when compared with those who consumed less protein, according to research being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

Zebrafish teach researchers more about atrial fibrillation
Genetic research in zebrafish at the University of Copenhagen has surprised the researchers behind the study.

Personalized medicine for atrial fibrillation
The study, published in Europace, uses signals from implantable devices -- pacemakers and defibrillators -- to analyze electrical signals in the heart during episodes of atrial fibrillation.

Prescribing anticoagulants in the ED for atrial fibrillation increases long-term use by 30%
Patients prescribed anticoagulants after a diagnosis of atrial fibrillation in the emergency department are more likely to continue long-term use of medications to treat the condition, according to research published in CMAJ (Canadian Medical Association Journal).

Anticoagulant benefits for atrial fibrillation decrease with age
The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

Research improves understanding of mechanism of atrial fibrillation
Mouse model studies show that noncoding DNA regions linked to atrial fibrillation risk can display long-range regulatory functions directed at Pitx2 gene and in this way predispose to the condition.

Read More: Atrial Fibrillation News and Atrial Fibrillation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.